PsyMed Ventures

PsyMed Ventures invests in early-stage companies advancing mental and brain health, with particular focus on psychedelics medicine, neurotechnology, precision psychiatry, and digital therapeutics. The firm deploys capital through a venture fund and an angel syndicate and provides operational support to founders. Category: venture capital / investment syndicate focused on psychedelic compounds, neurotech, human augmentation, and digital therapeutic platforms. PsyMed Ventures is based in San Francisco and was founded in 2020.